Literature DB >> 7426580

Desferrioxamine in ocular siderosis: a long-term electrophysiological evaluation.

S S Declercq.   

Abstract

Fourteen rabbits received an intravitreal iron foreign body and were treated with desferrioxamine. Their electroretinographic (ERG) values were recorded and compared with those of an untreated group. With desferrioxamine treatment a delay of the siderotic damage and preservation of better ERG potentials is observed.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7426580      PMCID： PMC1043770          DOI： 10.1136/bjo.64.8.626

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  7 in total

1.  THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.

Authors:  H KEBERLE
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

2.  Continuous subcutaenous administration of deferoxamine in patients with iron overload.

Authors:  R D Propper; B Cooper; R R Rufo; A W Nienhuis; W F Anderson; H F Bunn; A Rosenthal; D G Nathan
Journal:  N Engl J Med       Date:  1977-08-25       Impact factor: 91.245

3.  Long-term desferrioxamine therapy in thalassemia.

Authors:  C B Modell; J Beck
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

4.  Treatment of ocular siderosis and haemochromatosis with desferrioxamine.

Authors:  I Falbe-Hansen
Journal:  Acta Ophthalmol (Copenh)       Date:  1966

5.  Treatment of experimental siderosis bulbi, vitreous hemorrhage, and corneal blood staining with deferoxamine.

Authors:  J B Wise
Journal:  Arch Ophthalmol       Date:  1966-05

6.  Experimental siderosis in the rabbit: correlation between electroretinography and histopathology.

Authors:  S S Declercq; P C Meredith; A R Rosenthal
Journal:  Arch Ophthalmol       Date:  1977-06

7.  Desferrioxamine B in ophthalmology. Applications and therapeutic possibilities.

Authors:  A Valvo
Journal:  Am J Ophthalmol       Date:  1967-01       Impact factor: 5.258
  7 in total
  2 in total

1.  Studies on the use of desferrioxamine in experimental ocular siderosis produced by extrabulbar administration of iron.

Authors:  K Gerkowicz; M Prost
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

2.  Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature.

Authors:  Mohamed Belmouhand; Christina Eckmann-Hansen; Tomas Ilginis; Eva Birgitte Leinøe; Bo Kok Mortensen; Michael Larsen
Journal:  BMC Ophthalmol       Date:  2021-07-13       Impact factor: 2.209
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.